Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2006-04-10
2009-02-24
Gitomer, Ralph (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
Reexamination Certificate
active
07494783
ABSTRACT:
The invention provides methods/kits for assessing levels of trait or state anxiety in a subject by comparing genotypes and/or expression patterns at the ACHE, PON1 and/or BChE genes to the genotype and/or expression pattern of the genes in a reference population whose genotype and/or expression pattern of the genes is known or by correlating AChE levels activity to those of PON.
REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 6300063 (2001-10-01), Lipshutz et al.
patent: 6746850 (2004-06-01), Feaster et al.
patent: 2002/0009730 (2002-01-01), Chenchick et al.
patent: 2003/0036632 (2003-02-01), Soreq et al.
patent: 2003/0082548 (2003-05-01), Shu et al.
patent: 2003/0162207 (2003-08-01), Comings et al.
patent: 2003/0175210 (2003-09-01), Leyland-Jones
patent: 0717113 (1996-06-01), None
patent: 0730663 (1996-09-01), None
patent: WO 92/15712 (1992-09-01), None
patent: WO 97/02102 (1997-01-01), None
patent: WO 97/04127 (1997-02-01), None
patent: WO 97/29212 (1997-08-01), None
patent: WO 2004/029290 (2004-04-01), None
patent: WO 2004/029290 (2004-04-01), None
Sklan E. et al. Acetylcholinesterase/Paraoxonase Genotype and Expression Predict Anxiety Scores . . . PNAS 101(15)5512-17, Apr. 13, 2004.
Mathew R. et al. True and Pseudo Cholinesterases in Depression. American J Psychiatry 139(1)125-127, 1982.
Modai I. et al. Serum Pseudocholinesterase in State Anxiety. J Clinical Psychiatry 48(5)204-6, May 1987.
Abrams et al. “Comprehensive Detection of Single Base Changes in Human Genomic DNA Using Denaturing Gradient Gel Electrophoresis and A GC Clamp”, Genomics, 7: 463-475, 1990.
Abravaya et al. “Detection of Point Mutations With A Modified Ligase Chain Reaction (Gap-LCR)”, Nucleic Acids Research, 23(4); 675-682, 1995.
Abravaya et al. “Molecular Beacons as Diagnostic Tools: Technology and Applications”, Clinical and Chemical Laboratory Medicine, 41(4): 468-474, 2003.
Akhmedova et al. “Paraoxonase 1 Met-Leu 54 Polymorphism Is Associated With Parkinson's Disease”, Journal of Neurological Sciences, 184(2); 179-182, 2001. p. 180, col. 1-2, § 2, p. 181, col. 1-2, § 3, Abstract.
Akula et al. “Utility and Accuracy of Template-Directed Dye-Terminator Incorporation With Fluorescence-Polarization Detection for Genotyping Single Nucleotide Polymorphisms”, BioTechniques, 32(5): 1072-1078, 2002.
Anisman et al. “Cytokines, Stress and Depressive Illness: Brain-Immune Interactions”, Annal of Medicine, 35: 2-11, 2003.
Aviram et al. “Paraoxonase Inhibits High-Density Lipoprotein Oxidation and Preserves Its Functions”, Journal of Clinical Investigation, 101(8): 1581-1590, 1998.
Balciuniene et al. “Investigation of the Functional Effect of Monoamine Oxidase Polymorphisms in Human Brain”, Human Genetics, 110: 1-7, 2002.
Barany “Genetic Disease Detection and DNA Amplification Using Cloned Thermostable Ligase”, Proc. Natl. Acad. Sci. USA, 88: 189-193, 1991.
Bartels et al. “Mutation at Codon 322 in the Human Acetylcholinesterase (ACHE) Gene Accounts for YT Blood Group Polymorphism”, American Journal of Human Genetics, 52(5): 928-936, 1993.
Beaudet et al. “Homogeneous Assays for Single-Nucleotide Polymorphism Typing Using AlphaScreen”, Genome Research, 11: 600-608, 2001.
Bell et al. “SNPStream® UHT: Ultra-High Throughput SNP Genotyping for Pharmacogenomics and Drug Discovery”, BioTechniques Supplements, 32: S70-S77, 2002.
Bernik et al. “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway”, Journal of Experimental Medicine, 195(6): 781-788, 2002.
Birikh et al. “Interaction of ‘Readthrough’ Acetylcholinesterase With RACK1 and PKCβII Correlates With Intensified Fear-Induced Conflict Behavior”, Proc. Natl. Acad. Sci. USA, 100(1): 283-288, 2003.
Blatter Garin et al. “Paraoxonase Polymorphism Met-Leu54 Is Associated With Modified Serum Concentrations of the Enzyme”, Journal of clinical Investigation, 99(1): 62-66, 1997.
Blatter Garin et al. “Paraoxonase Polymorphism Met-Leu54 Is Associated With Modified Serum Concentrations of the Enzyme”, Journal of Clinical Investigations, 99(1): 62-66, 1997. p. 63, col. 1, Lines 10-65, Abstract.
Blumenthal et al. “Contribution of Job Strain, Job Status and Marital Status to Laboratory and Ambulatory Blood Pressure in Patients With Mild Hypertension”, Journal of Psychosomatic Research, 39(2): 133-144, 1995.
Børresen et al. “Constant Denaturant Gel Electrophoresis as A Rapid Screening Technique for P53 Mutations”, Proc. Natl. Acad. Sci. USA, 88: 8405-8409, 1991.
Bouchard et al. “Aims, Design, and Measurement Protocol”, Medicine and Science in Sports and Exercise, 27: 721-729, 1995.
Brenner et al. “The role of Readthrough Acetylcholinesterase in the Pathophysiology of Myasthenia Gravis”, The FASEB Journal, 17: 214-222, 2003.
Brophy et al. “Effects of 5′ Regulatory-Region Polymorphisms on Paraoxonase-Gene (PON1) Expression”, American Journal of Human Genetics, 68: 1428-1436, 2001.
Carmine et al. “Further Evidence for An Association of the Paraoxonase 1 (PON1) Met-54 Allele With Parkinson' Disease”, Movement Disorders, 17(4): 764-766, 2002. p. 765, Table 1, col. 1, Line 34-col. 2, Line 29.
Cashman et al. “Population Distribution of Human Flavin-Containing Monooxygenase Form 3: Gene Polymorphisms”, Drug Metabolism and Disposition, 29(12): 1629-1637, 2001.
Cohen et al. “Endotoxin-Induced Changes in Human Working and Declarative Memory Associate With Cleavage of Plasma “Readthrough” Acetylcholinesterase”, Journal of Molecular Neuroscience, 21: 199-212, 2003.
Cohen et al. “Neuronal Overexpression of ‘Readthrough’ Acetylcholinesterase Is Associated With Antisense-Suppressible Behavioral Impairments”, Molecular Psychiatry, 7: 874-885, 2002.
Conner et al. “Detection of Sickle Cell βS-Globin Allele by Hybridization With Synthetic Oligonucleotides”, Proc. Natl. Acad. Sci. USA, 80: 278-282, 1983.
Costa et al. “Functional Genomics of the Paraoxonase (PON1) Polymorphisms: Effect on Pesticide Sensitivity, Cardiovascular Disease, and Drug Metabolism”, Annual Reviews in Medicine, 54: 371-392, 2003.
Cotton et al. “Reactivity of Cytosine and Thymine in Single-Base-Pair Mismatches With Hydroxylamine and Osmium Tetroxide and Its Application to the Study of Mutations”, Proc. Natl. Acad. Sci. USA, 85: 4397-4401, 1988.
Curcio et al. “Multiplex High-Throughput Solid-Phase Minisequencing by Capillary Electrophoresis and Liquid Core Waveguide Fluorescence Detection”, Electrophoresis, 23: 1467-1472, 2002.
Curley et al. “Isoform—Specific Effects of Apoe on Anxiety in Probable Ad Patients and Apoe-/- Mice”, 2002: P. Abstract No. 883.2, 2002. Database BIOSIS 'Online! Bioscience Information Service, Database Acc. No. PREV200300379477 & Society for Neuroscience Abstract Viewer and Itinery Planner, vol. 2002: P.Abstract No. 883.2, 32nd Annual Meeting for the Society for Neuroscience, Orlando, Fa., USA, 2002.
Dantoine et al. “Implication des Facteurs Vasculaires dans les Troubles Cognitifs du Sujet Âgé: Relation Entre le Polymorphisme 192 de la Paraoxonase 1 et la Maladie d'Alzheimer”, Revue de Medicine Interne, P.606S, 2002. Abstract.
Davies et al. “The Effect of the Human Serum Paraoxonase Polymorphism Is Reversed With Diazoxon, Soman and Sarin”, Nature Genetics, 14: 334-336, 1996.
Day et al. “High-Throughput Genotyping Using Horizontal Polyacrylamide Gels With Well Arranged for Microplate Array Diagonal Gel Electrophoresis (MADGE)”, BioTechniques, 19(5): 830-835, 1995.
Deustch et al. “ARP—A Novel Hematopoietic Growth Factor and Stress Signal Derived From Acetylcholinesterase”, Blood, 94: 46A, 1999. Abstract.
Dragano
Ailon Keren
Shapira-Lichter Irit
Sklan Ella
Soreq Hermona
Yirmiya Raz
Gitomer Ralph
Yissum Research Development Company of the Hebrew University of
LandOfFree
Method for assessing trait anxiety by determining... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for assessing trait anxiety by determining..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for assessing trait anxiety by determining... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4083911